FTY720, a New Immunosuppressant, Promotes Long-Term Graft Survival and Inhibits the Progression of Graft Coronary Artery Disease in a Murine Model of Cardiac Transplantation
- 21 September 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 100 (12) , 1322-1329
- https://doi.org/10.1161/01.cir.100.12.1322
Abstract
Background—Effective immunosuppression is a critical determinant of organ and patient survival in cardiac transplantation. The present study was designed to determine the potency of FTY720, a new s...Keywords
This publication has 22 references indexed in Scilit:
- MHC CLASS II EXPRESSION ON HUMAN HEART MICROVASCULAR ENDOTHELIAL CELLSTransplantation, 1997
- Cytokines and the immune responseBiotherapy, 1996
- QUANTITATING IMMUNOSUPPRESSIONTransplantation, 1996
- Immunomodulation by an Adenylate Cyclase Activator, NKH477,in Vivoandin VitroClinical Immunology and Immunopathology, 1996
- Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.Journal of Clinical Investigation, 1996
- Immunosuppression in cardiac transplantationCurrent Opinion in Cardiology, 1995
- UPREGULATION OF CYTOKINES ASSOCIATED WITH MACROPHAGE ACTIVATION IN THE LEWIS-TO-F344 RAT TRANSPLANTATION MODEL OF CHRONIC CARDIAC REJECTION1,2Transplantation, 1995
- CARDIAC ALLOGRAFT ATHEROSCLEROSIS IN THE RATTransplantation, 1994
- TREATMENT WITH ANTI-VASCULAR CELL ADHESION MOLECULE 1 MONOCLONAL ANTIBODY INDUCES LONG-TERM MURINE CARDIAC ALLOGRAFT ACCEPTANCETransplantation, 1993
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992